J&J-Merck team up in Canada, plan for Pepcid AC launch in first half of 1996.
This article was originally published in The Tan Sheet
Executive Summary
NEW J&J-MERCK CANADIAN JOINT VENTURE TARGETS PEPCID AC LAUNCH for the first half on 1996. The nonprescription famotidine will be the first of several potential Rx-to-OTC switch products developed by Merck that are slated for marketing in Canada through the venture. The companies also will contribute a number of their existing OTC brands from their respective Canadian businesses.